Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Company

Edwards Lifesciences

Tracked across 3 events · 20 articles · First seen May 04, 2026 · Last active Aug 20, 2026

Sentiment
28
Attention
4
Events
3
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 75
Tech
Impact: Edwards Lifesciences announced positive 10-year results from its COMMENCE aortic trial, reinforcing the long-term durability and sustained performance of its RESILIA tissue, which is expected to positively impact its market position and growth.
May 04, 2026 · 6 articles
0 10
Business
Edwards Lifesciences held its annual Asia-Pacific Patient Experience event in Singapore, bringing together patients from Australia, India, Indonesia, South Korea, and Singapore to share their experiences with structural heart disease. The event aimed to foster…
Impact: Edwards Lifesciences organized and hosted the event, reinforcing its patient-focused culture and commitment to innovation in structural heart disease. The event may enhance its reputation and support long-term growth in the Asia Pacific market.
Jul 20, 2026 · 6 articles
2 0
Business
Impact: Edwards Lifesciences is mentioned as a previous employer of Tim Benner, providing context to his experience. No direct impact on the company.
Aug 03, 2026 · 8 articles
ERGEN INTELLIGENCE
Track Edwards Lifesciences live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.